Hadasit Bio (HDST) — Long-term Investment Intensity
Hadasit Bio (HDST) has a Long-term Investment Intensity of 67.9% as of June 2019. Long-term investments of ILA12.04 Million represent 67.9% of total assets of ILA17.73 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check HDST operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Hadasit Bio Long-term Investment Intensity (2013–2018)
This chart shows how Hadasit Bio's Long-term Investment Intensity has evolved across 6 annual periods from 2013 to 2018. As of June 2019, the intensity stands at 67.9%, reflecting long-term investments of ILA12.04 Million against total assets of ILA17.73 Million ILA. Explore Hadasit Bio cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Hadasit Bio (2013–2018)
The table below presents the year-by-year Long-term Investment Intensity for Hadasit Bio from 2013 to 2018, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Hadasit Bio market capitalisation.
| Year | LT Investment Intensity | LT Investments (ILA) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 48.0% | ILA16.97 Million | ILA35.34 Million | ▲ +34.1 pp |
| 2017 | 13.9% | ILA9.53 Million | ILA68.60 Million | ▼ -5.1 pp |
| 2016 | 19.0% | ILA13.21 Million | ILA69.46 Million | ▲ +15.3 pp |
| 2015 | 3.7% | ILA2.54 Million | ILA68.61 Million | ▼ -10.4 pp |
| 2014 | 14.2% | ILA4.59 Million | ILA32.42 Million | ▼ -11.9 pp |
| 2013 | 26.0% | ILA9.05 Million | ILA34.76 Million | — |